Assay

miRNA Sequencing And Assay Market Research Report 2021 - ResearchAndMarkets.com

Friday, July 30, 2021 - 11:28am

The "miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report by Product & Service, by Technology, by Workflow, by Application (Cancer, Autoimmune Disease, Schizophrenia), by End-use, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report by Product & Service, by Technology, by Workflow, by Application (Cancer, Autoimmune Disease, Schizophrenia), by End-use, by Region, and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global miRNA sequencing and assay market size is expected to reach USD 597.8 million by 2028.
  • Moreover, these companies have collaborated with research institutes to expand the application of miRNA sequencing and assay in research studies.
  • The market holds a significant growth potential owing to the increasing application of miRNA sequencing and assay in the healthcare industry.

A.Menarini Diagnostics launches a new Real Time PCR kit for SARS CoV-2 detection and variant screening, CE marked.

Thursday, July 29, 2021 - 7:40pm

FLORENCE, Italy, July 29, 2021 /PRNewswire/ -- Menarini Diagnostics, part of the Menarini Group, announced today the release of a new version of the CoronaMelt Kit launched in November 2020.

Key Points: 
  • FLORENCE, Italy, July 29, 2021 /PRNewswire/ -- Menarini Diagnostics, part of the Menarini Group, announced today the release of a new version of the CoronaMelt Kit launched in November 2020.
  • The second-generation kit, CoronaMelt VAR, will combine SARS CoV-2 viral detection with concurrent genotyping of Alpha, Beta and Gamma variants (formerly known as UK, South African and Brazilian) in an IVD certified diagnostic format validated for use on laboratory Real Time PCR instruments.
  • CoronaMelt VAR is validated for use from oro/nasopharyngeal swabs with the use of standard magnetic bead or column RNA purification solution.
  • The kit is also included in the portfolio of assays that can be fully automated on the Omnia liquid handling series.

Tempus Unveils Its Scalable Tumor Organoid Screening Platform In Cell Reports Study

Wednesday, July 28, 2021 - 4:30pm

Tempus , a leader in artificial intelligence and precision medicine, today announced publication of a study outlining the precision medicine applications for its patient-derived tumor organoid (TO) platform.

Key Points: 
  • Tempus , a leader in artificial intelligence and precision medicine, today announced publication of a study outlining the precision medicine applications for its patient-derived tumor organoid (TO) platform.
  • Given the scale of Tempus organoid program, it now houses one of the largest repositories of these models in the world.
  • Overall, the Tempus organoids accurately represented patients tumor DNA mutational profiles, RNA expression, and structural genomic features.
  • Lastly, the study presents a neural network-based, universal solid tumor therapeutic profiling assay predicting organoid viability from simple light microscopy, reducing cost and time in high-throughput screening.

Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Report 2021-2025: Market is Poised to Grow by $265.55 Million - Increase in Chronic Diseases Driving Market Growth - ResearchAndMarkets.com

Wednesday, July 28, 2021 - 1:49pm

The "Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The report on the enzyme-linked immunosorbent assay (Elisa) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The enzyme-linked immunosorbent assay (Elisa) testing market analysis includes the end-user segment and geographic landscape.
  • This study identifies the increase in chronic diseases as one of the prime reasons driving the enzyme-linked immunosorbent assay (Elisa) testing market growth during the next few years.

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Wednesday, July 28, 2021 - 1:00pm

Researchers will now be able to choose between PerkinElmers HTRF or AlphaLISA assays to use the best methods for their individual labs.

Key Points: 
  • Researchers will now be able to choose between PerkinElmers HTRF or AlphaLISA assays to use the best methods for their individual labs.
  • The Companys AlphaLISA and HTRF kits are the first ready-to-use homogenous assays for KRAS/SOS1 inhibition analysis on the market.
  • PerkinElmers AlphaLISA and HTRF kits streamline workflows by offering fully validated kits to identify novel KRAS inhibitors in a no-wash format with no optimization necessary, and each kit comes with recombinant proteins, detection reagents, and assay buffers.
  • Because KRAS mutations are found in numerous types of cancer, from lung to colorectal to pancreatic cancers, its a prime drug target.

5 Reasons Why The Next Gold Rush Will Happen In Canada

Wednesday, July 28, 2021 - 1:00pm

During historical production, the main focus was on copper, while gold was treated as a secondary product.

Key Points: 
  • During historical production, the main focus was on copper, while gold was treated as a secondary product.
  • Additionally, high-resolution drone mag surveying covering the entire property was conducted to define gold structures and help identify drill targets.
  • In December last year, Starr Peak received high-grade gold results from grab samples taken on a field visit carried out in September 2020.
  • Highlight assay results sampled on Turgeon Lakeshoreline returned 157, 31.8 and 9.77 g/t Au, confirming the historical grab samples at Turgeon Lake gold showing.

5 Reasons Why The Next Gold Rush Will Happen In Canada

Wednesday, July 28, 2021 - 1:00pm

LONDON, July 28, 2021 /PRNewswire/ -- A new gold exploration in Quebec may be starting to ping radar because it keeps on hitting new mineralization and reports say it's gone beyond gold. Mentioned in today's commentary includes: Sociedad Química y Minera de Chile S.A. (NYSE: SQM), Freeport-McMoRan Inc. (NYSE: FCX), Gold Fields Limited (NYSE: GFI), Compañía de Minas Buenaventura S.A.A. (NYSE: BVN), Harmony Gold Mining Company Limited (NYSE: HMY).

Key Points: 
  • During historical production, the main focus was on copper, while gold was treated as a secondary product.
  • Additionally, high-resolution drone mag surveying covering the entire property was conducted to define gold structures and help identify drill targets.
  • In December last year, Starr Peak received high-grade gold results from grab samples taken on a field visit carried out in September 2020.
  • Highlight assay results sampled on Turgeon Lakeshoreline returned 157, 31.8 and 9.77 g/t Au, confirming the historical grab samples at Turgeon Lake gold showing.

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Wednesday, July 28, 2021 - 12:00pm

Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.

Key Points: 
  • Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.
  • Featuring antibodies from PROGEN, the Simple Plex AAV2 viral titer assay detects assembled viral capsids as well as the comprehensively characterized AAV2 standard to deliver industry leading specificity.
  • Available on the Ella platform, the Simple Plex AAV2 assay utilizes the recombinant AAV2 antibody (A20R) from industry leader PROGEN to quantify assembled AAV2 capsids.
  • "Working with ProteinSimple to develop the Simple Plex AAV2 assay was a great experience," said Katja Betts, CEO of PROGEN.

Two Day Online Seminar for Designing and Sustaining New and Existing Pharma/Biotech Product Stability Testing Program (October 6-7, 2021) - ResearchAndMarkets.com

Monday, July 26, 2021 - 1:54pm

Performing an effective sampling plan and utilizing the appropriate sample size for a stability testing program.

Key Points: 
  • Performing an effective sampling plan and utilizing the appropriate sample size for a stability testing program.
  • Performing a compliant sample analysis, handling and effecting the appropriate test specification for the product type.
  • How to Effectively Handle, Manage Data, Utilize and Perform the Trending of Stability Testing Results and Data.
  • Knowledge Base: Attendees will gain an understanding in the following key areas:
    How to perform Quality Control Testing, Setting Test Specification and Assay Release Process in a Stability Testing Program.

NuProbe Announces New Research and New Product on DNA Microsatellite Instability

Monday, July 26, 2021 - 5:00pm

Simultaneously, the company announced the release of the VarTrace MSI qPCR research use only assay for detection of DNA microsatellite instability (MSI) from tissue or blood specimens.

Key Points: 
  • Simultaneously, the company announced the release of the VarTrace MSI qPCR research use only assay for detection of DNA microsatellite instability (MSI) from tissue or blood specimens.
  • By constructing and experimentally validating a thermodynamic model of DNA microsatellite binding, NuProbe scientists overcame the challenges associated with MSI detection.
  • "The NuProbe VarTrace MSI qPCR assay allows qPCR-based detection of MSI from tumor tissue and cell-free DNA," said Alessandro Pinto, Ph.D., Associate Director of Product at NuProbe USA.
  • This allows the NuProbe product to be applied to cell-free DNA from peripheral blood plasma as well as to formalin-fixed, paraffin-embedded (FFPE) tumor tissue.